Flublok
STN: 125285
Proper Name: Influenza Vaccine
Tradename: Flublok
Manufacturer: Protein Sciences Corporation
Indication:
- Flublok is indicated for active immunization for the prevention of disease caused by influenza A virus subtypes and influenza type B virus represented by antigens contained in the vaccine.
Product Information
Supporting Documents
- July 1, 2026 Approval Letter - Flublok
- July 1, 2025 Approval Letter - Flublok
- March 31, 2025 Approval Letter - Flublok
- March 19, 2025 Clinical Review Memo - Flublok Quadrivalent
- Statistical Review - Flublok Quadrivalent & Flublok
- October 15, 2024 Approval Letter - Flublok
- July 1, 2024 Approval Letter - Flublok
- June 30, 2023 Approval Letter - Flublok and Flublok Quadrivalent
- July 7, 2017 Approval Letter - Flublok
- Approval History, Letters, Reviews, and Related Documents - Flublok
- Supporting Documents older than three years - Flublok